InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Insomnia, Brexit and the UPC: a fictional scenario


In our latest article looking at a UPC scenario, Nicola Dagg, Marc Döring, Alex Woolgar, David Por, Philipp Cepl and Laura Thompson consider a case that raises questions about jurisdiction, discovery and Brexit

In this fictional scenario our client is US-based innovative pharmaceutical company, Jones Pharma Inc. Jones manufactures and markets worldwide a medical device for the treatment of insomnia and related sleep disorders, branded SeroNight. SeroNight is a transdermal patch containing a...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @RebCrandall: .@TTABlog says he never wants to hear @theslants again. 😂®️ #INTA2018 https://t.co/Z827Tek4up

May 23 2018 06:22 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @RebCrandall: This is great - a #TTAB case review by @TTABlog. He even mentioned my pet peeve of how the @uspto usually thinks #craftbee…

May 23 2018 06:21 ·  reply ·  retweet ·  favourite
ManagingIP profile

John Welch outlines three rants he has given up on. But proportionality and the weaponisation of discovery is still… https://t.co/bEn2YiDc6t

May 23 2018 06:18 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


null

null null null

null null null

May 2018

Technology alters the anti-counterfeiting landscape

Ellie Mertens reveals evolving technologies are changing the counterfeiting game on both sides, as a tool for both prevention and evasion



Most read articles

Supplements